ストックスクリーナーアプリを入手
8.74
4.30%
0.36
アフターアワーズ：
8.74
Adicet Bio Inc (ACET) 最新ニュース
RA Capital discloses 9.99% Adicet Bio (ACET) stake with warrant blocker - Stock Titan
Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET) - Seeking Alpha
Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet - Zacks Investment Research
Adicet Bio (ACET) Edges Higher to $8.26 as Biotech Stock Consolidates Between Key LevelsVanna Flow - dars.gov.et
HC Wainwright Has Strong Estimate for Adicet Bio Q3 Earnings - MarketBeat
Adicet Bio at Canaccord Genuity: lupus data drives next step By Investing.com - Investing.com Canada
Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy - MarketBeat
All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy - newsbreak.com
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $27 - Moomoo
JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Price to sales forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Press Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - crisprmedicinenews.com
Guggenheim cuts Adicet Bio stock price target to $90 on cash position - Investing.com UK
CCORF Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Adicet Bio, Inc. Stock 12‑Month Price Target Cut to $34.4, Implies 276% Upside - TradingView
ADICET BIO Q2 NET INCOME USD -21.358 MILLION - Moomoo
ADICET Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Adicet Bio (NASDAQ:ACET) Posts Earnings Results, Misses Estimates By $0.30 EPS - MarketBeat
Adicet Bio Q2 net loss narrows - TradingView
Adicet Bio reports Q2 2026 net loss $21.4M; cash runway into H2 2027, clinical updates planned - TradingView
Adicet Bio, Inc. 2Q 2026: Revenue $0 Net loss $(21.4)M, EPS $(1.99) — 10-Q Summary - TradingView
ACET: Q2 2026 net loss narrowed 32% year-over-year; cash runway extends into H2 2027 - TradingView
BRIEF-Adicet Bio Q2 Basic EPS USD -1.99 - TradingView
ACET Q2'26 Earnings: EPS estimate is (1.69) USD - TradingView
More Than Two Decades at Johnson & Johnson: Lipocine's New Director - stocktitan.net
Adicet Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView
Adicet Bio Inc Actuals & Estimates (NASDAQ:ACET) - TradingView
Adicet Bio (ACET) Projected to Release Quarterly Earnings on Thursday - MarketBeat
Adicet Bio, Inc. Revenue Breakdown – NASDAQ:ACET - TradingView
Adicet Bio Inc (ACET) Balance Sheet - TradingKey
Adicet Bio Inc (ACET) Cash Flow - TradingKey
Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data - Kavout | AI
Adicet Bio Inc Revenue Breakdown – TRADEGATE:1IJ - TradingView
Adicet Bio Inc (ACET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adicet Bio Inc (ACET) Income Statement - TradingKey
Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adicet Bio Inc (ACET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis - TradingKey
ACET|Adicet Bio Inc|Price:8.140|Chg%:+0.350 - TradingKey
Adicet Bio Market Sentiment - Benzinga España
Adicet Bio Inc (ACET) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - BioSpace
Adicet Bio (NASDAQ:ACET) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Price to earnings forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
Enterprise value to revenue forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
ACET Q1 2026 Earnings: Narrower Loss Beats Expectations Amid Pre-Revenue StageRevenue Surprise History - dars.gov.et
Adicet Bio (ACET) Proxy filing Summary - Quartr
Are medical stocks lagging Adicet Bio (ACET) this year? - MSN
Adicet Bio (ACET) Stock Analysis Report | Financials & Insights - Benzinga España
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index - marketscreener.com
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Index - marketscreener.com
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index - marketscreener.com
ACET Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Shares HigherBook Value Growth - dars.gov.et
1IJ Forecast — Price Target — Prediction for 2027 - TradingView
Adicet Bio Inc Actuals & Estimates (MUN:1IJ) - TradingView
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):